Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPCLD: Budesonide + Surfactant to Prevent CLD in Preterm Infants
NCT05364385Phase 4Unknown
- Sponsor
- University of Arizona
- Start
- Dec 2019
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in bronchopulmonary dysplasia (BPD), sponsored by University of Arizona. Status: unknown.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT05364385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364385.